Nucleus is a centralized AI-tool marketplace and governance platform — discover, evaluate, integrate, monitor, and manage AI tools in one environment. This room contains the commercial model, the technical architecture, and the working patent portfolio across six families.
Nucleus treats AI tools as certifiable, composable, monitorable components. Tool developers gain discoverability and enterprise credibility; enterprises gain governance, evaluation, compliance monitoring, and power visibility; creators get a practical way to understand how multiple tools interact. That position supports several revenue lines at once.
Nucleus Engine is the central registry and integration platform. Around it, specialized layers attach governance metadata to every tool and every execution — and feed operational evidence back into discovery, ranking, and policy.
| Data object | Example fields | Purpose |
|---|
Reference diagrams from the patent portfolio — integration and execution, governance and scoring, compliance and sustainability, and the data, audit, and feedback machinery that makes the marketplace self-improving.
The portfolio is organized as six families that each provide standalone claim space while supporting a broader integrated-platform claim. The strategy: an initial provisional covering all major systems to establish a broad priority date, then focused continuations per family. Inventor details available under NDA.
~79 drafted claims across the Engine (40) and Kitchen (39) tables, plus formal claim drafts in the appendix.
| Prior-art category | Known limitation | Nucleus differentiator |
|---|
Each layer protects a distinct part of the system; together they create a platform far more defensible than any one product — and they compound through data network effects from operational evidence and reviews.
An initial provisional can include all major systems and diagrams to establish a broad priority date. Later non-provisional filings separate the claims into focused families, preserving flexibility as counsel evaluates prior art.
| Priority | Family | Recommended coverage |
|---|
We're happy to walk through the architecture, the claim strategy, or the commercial model in a working session — and to share the full document under NDA.
CONFIDENTIAL. Provided solely for a limited number of prospective investors; not an offer to sell or a solicitation to buy any security. The patent portfolio is a working technical and strategic draft, not legal advice; claims and patentability conclusions must be reviewed by licensed patent counsel before filing, and references to claims describe drafts and filings in progress rather than granted patents. Commercial-model statements are forward-looking and not a forecast or guarantee. Recipients should conduct their own due diligence and consult their own legal, tax, and financial advisors.